Ravichandran, K., Pal, S., & Ikezu, T. (2026). Aptamer-based technologies for theranostics of central nervous system disorders. NeuroImmune Pharmacology & Therapeutics, 5(2), 205. https://doi.org/10.1515/nipt-2026-0009
Chicago Style (17th ed.) CitationRavichandran, Karthick, Sourav Pal, and Tsuneya Ikezu. "Aptamer-based Technologies for Theranostics of Central Nervous System Disorders." NeuroImmune Pharmacology & Therapeutics 5, no. 2 (2026): 205. https://doi.org/10.1515/nipt-2026-0009.
MLA (9th ed.) CitationRavichandran, Karthick, et al. "Aptamer-based Technologies for Theranostics of Central Nervous System Disorders." NeuroImmune Pharmacology & Therapeutics, vol. 5, no. 2, 2026, p. 205, https://doi.org/10.1515/nipt-2026-0009.
Warning: These citations may not always be 100% accurate.